XML 29 R8.htm IDEA: XBRL DOCUMENT v3.25.0.1
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
12 Months Ended
Dec. 28, 2024
Dec. 30, 2023
Dec. 31, 2022
Cash flows from operating activities:      
Net income $ 29,030 $ 53,115 $ 84,720
Adjustments to reconcile net income to net cash provided by operating activities:      
Stock-based compensation expense 61,636 72,604 1,943
Amortization of debt issuance costs and debt discount 5,611 6,051 4,005
Depreciation and amortization 69,530 61,144 55,753
Operating lease expense 132,173 119,908 114,788
Deferred income taxes, net (31,880) (35,249) 20,261
Loss on extinguishment of debt 4,088 16,626 1,023
Other items 9,048 (15,055) 22,795
Changes in operating assets and liabilities, net of acquisition:      
Trade receivables (5,748) 740 (8,053)
Inventories (1,898) (10,926) 2,246
Prepaid expenses and other current assets 1,073 3,659 (16,928)
Accounts payable and accrued liabilities (8,046) 8,154 6,887
Accrued payroll and related taxes (10,688) 2,428 (12,632)
Operating lease liabilities (122,630) (110,438) (104,685)
Other liabilities 2,977 2,404 (2,690)
Net cash provided by operating activities 134,276 175,165 169,433
Cash flows from investing activities:      
Purchases of property and equipment (105,877) (91,743) (110,173)
Settlement of derivative instruments, net 28,543 28 (329)
Business acquisition, net of cash acquired (3,189) 0 0
Purchase of trade name 0 (650) 0
Net cash used in investing activities (80,523) (92,365) (110,502)
Cash flows from financing activities:      
Proceeds from issuance of long-term debt, net 0 529,247 0
Principal payments on long-term debt (55,500) (547,931) (10,991)
Payment of debt issuance costs (1,004) (4,359) (626)
Prepayment premium on extinguishment of debt (1,485) (1,650) (1,023)
Advances on revolving line of credit 0 42,000 102,000
Repayments of revolving line of credit 0 (84,000) (60,000)
Proceeds from stock option exercises 3,721 0 0
Dividends paid 0 (262,235) (69,433)
Repurchase of common stock under share repurchase program (31,674) 0 0
Proceeds from initial public offering, net 0 314,719 0
Payment of offering costs 0 (9,061) 0
Repurchase of shares and shares withheld for taxes (560) (849) (292)
Settlement of derivative instrument, net 11,925 8,601 147
Principal payments on finance lease liabilities (1,615) (1,526) 0
Other (438) 0 0
Net cash used in financing activities (76,630) (17,044) (40,218)
Effect of exchange rate changes on cash and cash equivalents (7,111) 2,067 (4,496)
Net change in cash and cash equivalents (29,988) 67,823 14,217
Cash and cash equivalents at beginning of period 179,955 112,132 97,915
Cash and cash equivalents at end of period 149,967 179,955 112,132
Supplemental disclosures of cash flow information:      
Interest paid on debt 75,409 79,133 62,157
Income taxes paid, net 48,201 22,480 31,168
Supplemental disclosure of noncash investing activities:      
Noncash capital expenditures $ 3,787 $ 5,276 $ 6,414